![]() |
市場調查報告書
商品編碼
2020131
術中影像市場規模、佔有率、成長率及全球產業分析:按類型、應用和地區分類的洞察,2026-2034 年預測Intraoperative Imaging Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
全球術中影像市場在2025年達到30.9億美元,預計2026年成長至32.5億美元,並在2034年達到52.6億美元,預測期間內年複合成長率(CAGR)為6.18%。2025年,北美將以48.87%的市場佔有率引領市場,這得益於其先進的醫療基礎設施和影像技術的高普及率。
術中影像系統可在手術過程中即時提供高解析度影像,在提高手術精確度和治療效果方面發揮非常重要的作用,尤其是在微創手術中。
新冠疫情的影響
新冠肺炎疫情對市場造成了負面影響,因為手術延期和門診就診量減少。由於醫療系統優先應對疫情,對C臂和X光系統等影像設備的需求下降。然而,疫情過後,隨著手術量的增加和延期治療的恢復,市場出現了復甦跡象。
市場趨勢
影響市場的主要趨勢之一是C型臂技術的進步,特別是平板檢測器(FPD)的應用。與傳統系統相比,這些檢測器可提供更優異的影像品質、更高的空間解析度和更好的對比度。
此外,人工智慧(AI)與影像系統的融合增強手術過程中的即時決策能力。混合影像系統和行動裝置等創新技術提高工作流程效率,並擴大其在醫療機構中的應用範圍。
市場成長要素
慢性疾病(包括心血管疾病、癌症和整形外科疾病)盛行率的上升是推動需求成長的主要因素。此外,脊椎融合手術和心臟手術等外科手術數量的增加也提高了對高精度影像系統的需求。
技術進步和主要企業持續的產品創新進一步加速市場成長。例如,整合人工智慧和行動成像設備的新系統提高手術精度和患者療效。
另一個重要因素是從類比放射成像轉變數位放射線的方向。這帶來了影像品質的提高、輻射暴露的減少和處理時間的縮短。
抑制因子
術中影像系統的高成本是其普及應用的主要障礙,尤其是在發展中地區。先進的系統,例如全尺寸C型臂,造價可能在100萬至200萬美元之間,小規模醫療機構難以負擔。
此外,安裝、維護和營運成本進一步增加了經濟負擔,限制了它們在中低收入國家的普及。
依類型
C 型臂設備在市場上佔據主導地位,由於其在微創手術中的廣泛應用和持續的技術進步,預計到2026年將佔 68.21%的市場佔有率。
由於其卓越的3D 成像能力,O 型臂市場也在不斷成長。
依診斷成像方法
由於價格實惠且在新興市場廣泛應用,預計到2026年,2D成像領域將佔據市場主導地位,市場佔有率將達到 76.82%。
由於其精準性以及在複雜手術中日益成長的需求,3D影像領域迅速發展。
依最終用戶
到2026年,在手術數量增加和醫療基礎設施擴張的推動下,醫院和門診手術中心(ASC)預計將佔市場佔有率的75.87%。
隨著可攜式診斷成像系統的引進,專科診所預計將迎來穩步成長。
2026-2034年的年複合成長率為 6.18%。
The global intraoperative imaging market was valued at USD 3.09 billion in 2025 and is projected to grow to USD 3.25 billion in 2026, reaching USD 5.26 billion by 2034, registering a CAGR of 6.18% during the forecast period. North America dominated the market in 2025 with a 48.87% share, driven by advanced healthcare infrastructure and high adoption of imaging technologies.
Intraoperative imaging systems provide real-time, high-resolution visualization during surgical procedures, playing a vital role in enhancing precision and outcomes, particularly in minimally invasive surgeries.
Impact of COVID-19
The COVID-19 pandemic had a negative impact on the market due to postponement of elective surgeries and reduced hospital visits. Healthcare systems prioritized COVID-19 management, leading to lower demand for imaging equipment such as C-arms and X-ray systems. However, the post-pandemic period witnessed a recovery, supported by increased surgical volumes and the resumption of delayed procedures.
Market Trends
A key trend shaping the market is the advancement of C-arm technologies, particularly the adoption of flat-panel detectors (FPDs). These detectors offer superior image quality, higher spatial resolution, and better contrast compared to traditional systems.
Additionally, the integration of artificial intelligence (AI) in imaging systems is enhancing real-time decision-making during surgeries. Innovations such as hybrid imaging systems and portable devices are improving workflow efficiency and expanding applications in healthcare facilities.
Market Growth Drivers
The rising prevalence of chronic diseases, including cardiovascular conditions, cancer, and orthopedic disorders, is a major factor driving demand. Increasing numbers of surgical procedures, such as spinal fusion and heart-related surgeries, are boosting the need for accurate imaging systems.
Technological advancements and continuous product innovations by leading companies are further accelerating market growth. For instance, new AI-integrated systems and mobile imaging devices are improving surgical precision and patient outcomes.
Another important driver is the shift from analog to digital radiography, which provides better image quality, reduced radiation exposure, and faster processing times.
Restraining Factors
The high cost of intraoperative imaging systems is a significant barrier to adoption, particularly in developing regions. Advanced systems such as full-sized C-arms can cost between USD 1.0 million and USD 2.0 million, making them inaccessible for smaller healthcare facilities.
Additionally, installation, maintenance, and operational costs further increase the financial burden, limiting adoption in low- and middle-income countries.
By Type
The C-arms segment dominated the market and is expected to hold a 68.21% share in 2026, driven by widespread use in minimally invasive procedures and continuous technological advancements.
The O-arms segment is also growing due to its superior 3D imaging capabilities.
By Imaging
The 2D imaging segment is projected to dominate with a 76.82% share in 2026, owing to its affordability and widespread use in emerging markets.
The 3D imaging segment is gaining traction due to its precision and growing demand in complex surgeries.
By End User
The hospitals & ambulatory surgical centers (ASCs) segment accounted for 75.87% of the market share in 2026, driven by the increasing number of surgical procedures and healthcare infrastructure expansion.
Specialty clinics are expected to grow at a steady pace due to the adoption of portable imaging systems.
Competitive Landscape
The market is highly competitive, with major players such as GE Healthcare, Siemens Healthineers, and Koninklijke Philips N.V. leading the industry. Other key companies include Medtronic and Shimadzu Corporation.
These companies focus on product innovation, AI integration, and strategic collaborations to strengthen their market position and expand globally.
Conclusion
In conclusion, the intraoperative imaging market is expected to grow steadily from USD 3.09 billion in 2025 to USD 5.26 billion by 2034, driven by the increasing adoption of minimally invasive surgeries, rising prevalence of chronic diseases, and technological advancements in imaging systems. Despite challenges such as high costs and limited accessibility in developing regions, continuous innovation, digital transformation, and expanding healthcare infrastructure are expected to support long-term market growth. North America will remain dominant, while emerging regions will offer new growth opportunities in the coming years.
Growth Rate CAGR of 6.18% from 2026-2034
Segmentation By Type
By Imaging
By End User
By Region